Perspectives in Clinical Research

REGULATORY UPDATE
Year
: 2019  |  Volume : 10  |  Issue : 1  |  Page : 31--33

Indian regulatory update April–October 2018


Amita Bhave1, Lakhvinder Singh Batolar2 
1 Head Regulatory Affairs, Global Drug Development India, Novartis Healthcare Private Ltd., Mumbai, Maharashtra, India
2 General Regulator Affairs Manager, Johnson and Johnson Private Limited, Mumbai, Maharashtra, India

Correspondence Address:
Amita Bhave
Novartis Healthcare Private Limited, Inspire BKC, Part of 601 and 701, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051, Maharashtra
India

This document provides updates in regulatory requirements regarding conduct of clinical trials in India.


How to cite this article:
Bhave A, Batolar LS. Indian regulatory update April–October 2018.Perspect Clin Res 2019;10:31-33


How to cite this URL:
Bhave A, Batolar LS. Indian regulatory update April–October 2018. Perspect Clin Res [serial online] 2019 [cited 2019 Jul 19 ];10:31-33
Available from: http://www.picronline.org/article.asp?issn=2229-3485;year=2019;volume=10;issue=1;spage=31;epage=33;aulast=Bhave;type=0